Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
about
sameAs
Pleiotropic effects of statinsPrinciples of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisSmall G proteins in the cardiovascular system: physiological and pathological aspectsPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertensionTumor necrosis factor α decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limbRho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanismsCold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin.Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin.Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1Posttranscriptional and transcriptional regulation of endothelial nitric-oxide synthase during hypoxia: the role of microRNAs.Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea.The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway.The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinaseEfficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenonTreating pulmonary arterial hypertension: current treatments and future prospectsRho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.RhoA/Rho-kinase and vascular diseases: what is the link?Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells.Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyRho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans.Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction.Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathwayBeyond lipid-lowering: effects of statins on endothelial nitric oxide.Endothelial function in obstructive sleep apnea.Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury.Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia.Rho kinase as a therapeutic target in cardiovascular disease.Angiotensin II type I receptor blockade attenuates reflex cutaneous vasoconstriction in aged but not young skin.Overexpression of cationic amino acid transporter-1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cellsNitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.Post-Transcriptional Regulation of Endothelial Nitric Oxide Synthase Expression by Polypyrimidine Tract-Binding Protein 1.Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathwayIncreased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
P2860
Q24647863-70B09035-F360-4703-8E2C-50F0604CBCBFQ26859449-2CAE713C-09D3-4F4F-AE59-F5A47D1B3EA5Q27005980-BC3338AA-6BC4-434B-9F9B-342A9CF52169Q27010607-C28B2725-A319-4E6C-812C-D47BA3A07EDBQ27687091-BE45266C-B0CF-490C-9128-52F36BD46D00Q28566149-38E6C9C5-37F1-4BD1-A727-ECFB87871B7FQ28567166-C611B127-CDC3-4DD8-8036-4985112D02BFQ33260026-97FB72CE-E77E-40C0-A97D-798123483C6DQ33266719-9969BC4C-E96D-4A91-8A48-29C39907FC79Q33281441-41A9454B-90E5-4EBC-8DDC-34F590698868Q33358641-0917A644-DF33-4BA5-8EC6-E3224F85B19AQ33634719-595AC604-2970-4B92-BD7C-A98F08741594Q33748662-9B7232E3-0266-4717-A7D5-1E587C17B7F6Q33844443-F1DACACA-AF5F-45E5-97DD-4B7554A5BC6DQ33960556-1B890A62-0303-4A69-9FEF-42BB039FB3A4Q34082360-AED00629-CC25-4658-867A-1F09545D2B59Q34112875-CF95450E-4AF3-4A53-9D02-610C3BB7617EQ34139690-D2071EE8-CAB2-4528-8C8A-04F8E828B832Q34318473-3B17AA1D-D23C-4044-8E1F-C667B9BFCBF2Q34362144-F0858B53-893E-45F1-862B-8391B30176DEQ34378293-F68B07C7-4841-48E5-928C-58390260EB1BQ34426112-AD20154C-737E-4EE9-8A82-9D7C814C5152Q34429244-401CD23F-9520-4792-ACC8-6CCA33BFEF7CQ34617217-06FC4086-EDC7-4EFF-B8E2-0CF98393B105Q34632464-DBEF657C-C2E0-46F1-B329-590779EA16E6Q34980336-C3C56896-B5C3-43D1-85D3-FD5A78F226FEQ35056906-630AC137-0282-4EDE-A112-321AC1ECC039Q35084723-845D5BC0-8DB6-46C7-A30B-68E8C43698E1Q35086889-5B79072F-488A-48CE-9248-6F078E0D6DE0Q35123172-1CBD4AA9-417E-4923-AF02-A3455B0AC4E6Q35181215-D54CEF92-6B69-44D8-9052-88D13C625A29Q35352722-3EF32CF9-E202-4E95-AB3A-BFAA2CFA2D62Q35577220-AC837A66-B615-428B-8A05-12A534BA9F8EQ35577603-BF0B8232-F82D-456B-A7BD-F61F0580EE4BQ35625951-C27426AF-F781-4950-99EB-0575BA885585Q35665717-F358337A-864A-421C-AF3D-B070E9282FC3Q35751728-943A7930-5F91-4BE4-A11C-ED8E7F308FA8Q35832000-2DE4E1CB-9400-4D04-B0AD-E6DE04B7BC57Q35854712-D465A54B-7B1A-45B4-A864-E8E40C840974Q35905574-52EC1E36-681D-47BF-91BD-FC3570171E5A
P2860
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@ast
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@en
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@nl
type
label
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@ast
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@en
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@nl
prefLabel
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@ast
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@en
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@nl
P2093
P1433
P1476
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
@en
P2093
Hiroaki Shimokawa
James K Liao
Junko Hiroki
Masao Takemoto
P356
10.1161/01.CIR.0000020682.73694.AB
P407
P50
P577
2002-07-02T00:00:00Z